Caseware UK (AP4) 2025.0.111 2025.0.111 2026-08-312026-08-31truetruefalse2025-09-01trueNo description of principal activity11 01128997 2025-09-01 2026-08-31 01128997 2024-09-01 2025-08-31 01128997 2026-08-31 01128997 2025-08-31 01128997 c:Director1 2025-09-01 2026-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar 2026-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar 2025-08-31 01128997 d:CurrentFinancialInstruments 2026-08-31 01128997 d:CurrentFinancialInstruments 2025-08-31 01128997 d:CurrentFinancialInstruments d:WithinOneYear 2026-08-31 01128997 d:CurrentFinancialInstruments d:WithinOneYear 2025-08-31 01128997 d:ShareCapital 2026-08-31 01128997 d:ShareCapital 2025-08-31 01128997 d:RetainedEarningsAccumulatedLosses 2026-08-31 01128997 d:RetainedEarningsAccumulatedLosses 2025-08-31 01128997 c:OrdinaryShareClass1 2025-09-01 2026-08-31 01128997 c:OrdinaryShareClass1 2026-08-31 01128997 c:OrdinaryShareClass1 2025-08-31 01128997 c:EntityHasNeverTraded 2025-09-01 2026-08-31 01128997 c:FRS102 2025-09-01 2026-08-31 01128997 c:AuditExempt-NoAccountantsReport 2025-09-01 2026-08-31 01128997 c:FullAccounts 2025-09-01 2026-08-31 01128997 c:PrivateLimitedCompanyLtd 2025-09-01 2026-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2025-09-01 2026-08-31 01128997 e:PoundSterling 2025-09-01 2026-08-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 01128997









CYBERMED (U.K.) LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2026

 
CYBERMED (U.K.) LIMITED
REGISTERED NUMBER: 01128997

BALANCE SHEET
AS AT 31 AUGUST 2026

2026
2025
Note
£
£

Fixed assets
  

Intangible assets
  
-
2,833

  
-
2,833

  

Creditors: amounts falling due within one year
  
(159,049)
(158,267)

Net current liabilities
  
 
 
(159,049)
 
 
(158,267)

Total assets less current liabilities
  
(159,049)
(155,434)

  

Net liabilities
  
(159,049)
(155,434)


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
(159,149)
(155,534)

  
(159,049)
(155,434)


Page 1

 
CYBERMED (U.K.) LIMITED
REGISTERED NUMBER: 01128997
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2026

For the year ended 31 August 2026 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 15 October 2026.




M B Hughes
Director

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2026

1.


General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 01128997. The Company's registered office is 18 Hartford Close, Harborne, Birmingham, B17 8AU.

The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

Cash flow

Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.

 
2.2

Going concern

The company has made losses and as such has net liabilities at the balance sheet date.  The main creditors of the company are the director and shareholders who intend to continue to support the company for the foreseeable future and the director therefore considers it appropriate to prepare the accounts on a going concern basis.

 
2.3

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.4

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2025 - 1).

Page 3

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2026

4.


Taxation

The company has trading tax losses of £154,294 (2025 - £150,679) available to offset against future trading profits.


5.


Intangible assets




Patents

£



Cost


At 1 September 2025
50,996



At 31 August 2026

50,996



Amortisation


At 1 September 2025
48,163


Charge for the year on owned assets
2,833



At 31 August 2026

50,996



Net book value



At 31 August 2026
-



At 31 August 2025
2,833



6.


Creditors: Amounts falling due within one year

2026
2025
£
£

Other creditors
158,329
157,547

Accruals and deferred income
720
720

159,049
158,267


Page 4

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2026

7.


Share capital

2026
2025
£
£
Allotted, called up and fully paid



100 (2025 - 100) Ordinary shares of £1.00 each
100
100



8.


Related party transactions

As at 31 August 2026 amounts due to the director was £98,058 (2025 - £97,275) and amounts due to shareholders were £60,272 (2025 - £60,272).

All loans are interest free and repayable on demand.

 
Page 5